Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

143.97 +7.35 (+5.38%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

99 100 Next >

Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)

March 21, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including BioMarin Pharmaceutical (NASDAQ:BMRN) and its...

Via StockStory

Topics Artificial Intelligence

4 Things You Need to Know if You Buy Moderna Stock Today ↗

March 20, 2025

Via The Motley Fool

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

March 20, 2025

Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season.

Via StockStory

Topics Artificial Intelligence

2 No-Brainer Biotech Stocks to Buy Right Now ↗

March 19, 2025

Via The Motley Fool

Moderna Unusual Options Activity ↗

February 28, 2025

Via Benzinga

Which S&P500 stocks are gapping on Wednesday? ↗

March 19, 2025

Stay updated with the S&P500 gap up and gap down stocks on Wednesday. Get a glimpse of the market's movement during today's session.

Via Chartmill

A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

March 19, 2025

Let’s dig into the relative performance of Vertex Pharmaceuticals (NASDAQ:VRTX) and its peers as we unravel the now-completed Q4 therapeutics earnings season.

Via StockStory

Topics Artificial Intelligence

MarketBeat Week in Review – 03/10 - 03/14

March 15, 2025

Stocks continued to be under pressure on concerns over tariffs and growing inflation concerns, but history shows that corrections can set up opportunities

Via MarketBeat

Topics Economy World Trade

Down 93%, Is It Finally Time to Buy Moderna? ↗

March 15, 2025

Via The Motley Fool

10 Worst Performing Large-Caps Last 12 Months ↗

March 13, 2025

Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

Moderna Stock: A Deep Dive Into Analyst Perspectives (10 Ratings) ↗

March 13, 2025

Via Benzinga

3 Reasons MRNA is Risky and 1 Stock to Buy Instead

March 12, 2025

Moderna has gotten torched over the last six months - since September 2024, its stock price has dropped 51.2% to $33.99 per share. This was partly due to its softer quarterly results and might have...

Via StockStory

Top S&P500 movers in Tuesday's session ↗

March 11, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

What's going on in today's session: S&P500 movers ↗

March 11, 2025

Let's delve into the developments on the US markets in the middle of the day on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Gapping S&P500 stocks in Tuesday's session ↗

March 11, 2025

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index.

Via Chartmill

Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

March 11, 2025

Moderna stock has fallen to levels not seen in 5 years, but the CEO just spent $5 million buying stock in the open market underscoring his optimism for gains.

Via MarketBeat

Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

March 11, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at therapeutics stocks, starting with Myriad...

Via StockStory

Topics Artificial Intelligence

Where Will Vertex Pharmaceuticals Be in 10 Years? ↗

March 11, 2025

Via The Motley Fool

BioNTech Surpasses Q4 Revenue Estimates ↗

March 10, 2025

BioNTech SE exceeded earnings expectations with strong oncology pipeline development, despite reduced vaccine revenue.

Via The Motley Fool

Okta, Moderna and MicroStrategy Are Among Top 10 Large-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio? ↗

March 09, 2025

Top performing large-cap stocks last week: Okta, Moderna, Arcelor Mittal, MicroStrategy, ING Groep, POSCO, Elbit Systems, Trip.com, Eventbrite, Gold Fields, Rocket Companies.

Via Benzinga

Stay informed with the top movers within the S&P500 index on Friday. ↗

March 07, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Why Moderna Stock Has Surged 20% This Week Despite Mixed News ↗

March 07, 2025

Recent news has been mixed with a patent win and loss in Germany and the U.S. But Moderna stock has risen markedly this week.

Via Investor's Business Daily

Topics Intellectual Property

FDA Nominee Marty Makary Faces The Senate. Will He Toe The RFK Jr. Line? ↗

March 06, 2025

A Senate committee will vote Thursday on whether to endorse Dr. Marty Makary as the new commissioner of the Food and Drug Administration.

Via Investor's Business Daily

What's going on in today's pre-market session: S&P500 movers ↗

March 06, 2025

Get insights into the top gainers and losers in the S&P500 index of Thursday's pre-market session.

Via Chartmill

Why Moderna Stock Zoomed Nearly 16% Higher on Wednesday ↗

March 05, 2025

Via The Motley Fool

Exploring the top movers within the S&P500 index during today's session. ↗

March 05, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

Discover which S&P500 stocks are making waves on Wednesday. ↗

March 05, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Wednesday's pre-market session: top gainers and losers in the S&P500 index ↗

March 05, 2025

As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.

Via Chartmill

Coatue's Philippe Laffont Just Bought Shares of This Beaten-Down Growth Stock That Wall Street Predicts Will Soar 80% ↗

March 04, 2025

Via The Motley Fool

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

March 04, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including Sarepta Therapeutics (NASDAQ:SRPT) and its peers.

Via StockStory

Topics Artificial Intelligence

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.